
16.61 Delayed Data As of Mar 31 | ![]() Today’s Change | 4.98 Today|||52-Week Range 19.95 | +117.98% Year-to-Date |
BridgeBio Pharma (BBIO) Moves 9.7% Higher: Will This Strength Last? Mar 27 / Zacks.com - Paid Partner Content | BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why Mar 22 / Zacks.com - Paid Partner Content |
Previous close | 17.15 |
Today’s open | 17.23 |
Day’s range | 16.41 - 17.80 |
Volume | 127,621 |
Average volume (3 months) | 2,483,006 |
Market cap | $2.3B |
Earnings growth (last year) | +16.27% |
Earnings growth (this year) | +8.98% |
Earnings growth (next 5 years) | -51.17% |
Revenue growth (last year) | +11.38% |
P/E ratio | NM |
Price/Sales | 14.47 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
IDRSFIdorsia Ltd | -0.30 | -2.64% |
OASMYVivesto AB | 0.00 | 0.00% |
---- | ||
IMMBImmunotech Laborator... | 0.00 | 0.00% |
Next reporting date | May 4, 2023 |
EPS forecast (this quarter) | -$0.82 |
Annual revenue (last year) | $77.6M |
Annual profit (last year) | -$481.2M |
Net profit margin | -619.70% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |